Each Soft Gelatin Capsule Contains Paricalcitol USP 1mcg
It is indicated for the treatment and prevention of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4, Stage 5 in patients on hemodialysis (HD) or peritonial dialysis (PD).
Each Soft Gelatin Capsule Contains Paricalcitol USP 1mcg
It is indicated for the treatment and prevention of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4, Stage 5 in patients on hemodialysis (HD) or peritonial dialysis (PD).
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.